Search

Search Constraints

You searched for: Author/Creator Roy, Lydia

Search Results

1. Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the FIM and GEM French cooperative groups. (13th July 2013)

3. Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT. Issue 5 (May 2022)

4. Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study. Issue 10 (27th December 2016)

5. Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study. Issue 15 (27th May 2020)

7. Sustained treatment‐free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T‐cells. (12th March 2019)

8. Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study. Issue 1 (January 2015)

9. Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. (December 2017)

10. Evidence for eomesodermin‐expressing innate‐like CD8+ KIR/NKG2A+ T cells in human adults and cord blood samples. Issue 7 (20th May 2015)